HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue.

Abstract
The authors describe a 9 month old female with recurrent atypical central neurocytoma and leptomeningeal spread treated with high dose chemotherapy, autologous stem cell rescue, and adjuvant therapy. She had a complete response to therapy and was disease free at 4 years of age until a recurrence 6 months later. The use of intensive chemotherapy followed by autologous stem cell rescue for atypical neurocytoma may be considered as an adjunct to surgical therapy in young patients with atypical neurocytoma not amenable to radiation therapy.
AuthorsDavid Buchbinder, Moise Danielpour, William H Yong, Noriko Salamon, Joseph Lasky
JournalJournal of neuro-oncology (J Neurooncol) Vol. 97 Issue 3 Pg. 429-37 (May 2010) ISSN: 1573-7373 [Electronic] United States
PMID19924515 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Brain Neoplasms (complications, drug therapy, surgery)
  • Female
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Meningeal Neoplasms (complications, drug therapy, surgery)
  • Neurocytoma (complications, drug therapy, surgery)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: